Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-26 @ 4:07 AM
Study NCT ID:
NCT01958918
Status:
COMPLETED
Last Update Posted:
2019-03-21
First Post:
2013-10-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-07
First Submit QC Date:
None
Study First Post Date:
2013-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-17
Results First Submit QC Date:
None
Results First Post Date:
2019-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-12
Last Update Post Date:
2019-03-21
Last Update Post Date Type:
ACTUAL